Article
Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 May 2020
Procopio Fabio, Viganò Luca, Cimino Matteo, Donadon Matteo, Del Fabbro Daniele, Torzilli Guido
Abstract excerpt
INTRODUCTION: R0 margin is the standard in the surgical treatment of colorectal liver metastases (CLM). Recently R1 surgery, at least that enabling CLM vessel-detachment (R1vasc), seems comparable to R0. As a possible background of that biologic factors could play some role. Among them, KRAS has been investigated in the present study. METHODS: Patients who underwent curative surgery for CLM between 2008 and 2016...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
